Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Berger

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Population Health Management|November 28, 2025
Disparities in Recombinant Zoster Vaccine Coverage in the United StatesDavid Singer, Nikita Stempniewicz, Lydia Lee, et al.
European Journal of Clinical Pharmacology|June 28, 2006
Use of tricyclic antidepressants in older patients with painful neuropathiesAriel Berger, Ellen M Dukes, John Edelsberg, et al.
Clinical Therapeutics|May 18, 2012
Utilization and cost in clinical practice of darbepoetin alfa and epoetin alfa for anemia concomitant with chemotherapyAriel Berger, Claudia Lord, Patricia K Corey-Lisle, et al.
Infection Control and Hospital Epidemiology|January 9, 2008
Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infectionsJohn Edelsberg, Ariel Berger, David J Weber, et al.
The American Journal of Managed Care|July 1, 2010
Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgiaAriel Berger, Alesia Sadosky, Ellen M Dukes, et al.
Journal of Drugs in Dermatology : JDD|June 3, 2010
Cost-effectiveness of tacrolimus ointment versus pimecrolimus cream in adults with atopic dermatitisCharu Taneja, Richard J Antaya, Ariel Berger, et al.
The Annals of Pharmacotherapy|January 27, 2004
Economic consequences of venous thromboembolism following major orthopedic surgeryGerry Oster, Daniel A Ollendorf, Montserrat Vera-Llonch, et al.
The Annals of Pharmacotherapy|January 27, 2004
Therapy switching in patients receiving long-acting opioidsAriel Berger, Deborah L Hoffman, Seth Goodman, et al.
Influenza and Other Respiratory Viruses|December 1, 2025
Prevalence and Age at Diagnosis of Risk Factors for Severe Respiratory Syncytial Virus Disease Among US Adults: An Analysis of 2011-2020 NHANES DataEmily K Horn, David Singer, Alison Booth, et al.
Journal of Health Economics and Outcomes Research|March 1, 2024
Use of Healthcare Claims Data to Generate Real-World Evidence on Patients With Drug-Resistant Epilepsy: Practical Considerations for ResearchNicole Stamas, Tom Vincent, Kathryn Evans, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Population Health Management|November 28, 2025
Disparities in Recombinant Zoster Vaccine Coverage in the United StatesDavid Singer, Nikita Stempniewicz, Lydia Lee, et al.
European Journal of Clinical Pharmacology|June 28, 2006
Use of tricyclic antidepressants in older patients with painful neuropathiesAriel Berger, Ellen M Dukes, John Edelsberg, et al.
Clinical Therapeutics|May 18, 2012
Utilization and cost in clinical practice of darbepoetin alfa and epoetin alfa for anemia concomitant with chemotherapyAriel Berger, Claudia Lord, Patricia K Corey-Lisle, et al.
Infection Control and Hospital Epidemiology|January 9, 2008
Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infectionsJohn Edelsberg, Ariel Berger, David J Weber, et al.
The American Journal of Managed Care|July 1, 2010
Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgiaAriel Berger, Alesia Sadosky, Ellen M Dukes, et al.
Journal of Drugs in Dermatology : JDD|June 3, 2010
Cost-effectiveness of tacrolimus ointment versus pimecrolimus cream in adults with atopic dermatitisCharu Taneja, Richard J Antaya, Ariel Berger, et al.
The Annals of Pharmacotherapy|January 27, 2004
Economic consequences of venous thromboembolism following major orthopedic surgeryGerry Oster, Daniel A Ollendorf, Montserrat Vera-Llonch, et al.
The Annals of Pharmacotherapy|January 27, 2004
Therapy switching in patients receiving long-acting opioidsAriel Berger, Deborah L Hoffman, Seth Goodman, et al.
Influenza and Other Respiratory Viruses|December 1, 2025
Prevalence and Age at Diagnosis of Risk Factors for Severe Respiratory Syncytial Virus Disease Among US Adults: An Analysis of 2011-2020 NHANES DataEmily K Horn, David Singer, Alison Booth, et al.
Journal of Health Economics and Outcomes Research|March 1, 2024
Use of Healthcare Claims Data to Generate Real-World Evidence on Patients With Drug-Resistant Epilepsy: Practical Considerations for ResearchNicole Stamas, Tom Vincent, Kathryn Evans, et al.
Pageof 7